Carbon nanoparticles in lateral flow methods to detect genes encoding virulence factors of Shiga toxin-producing Escherichia coli by Noguera, P. et al.
ORIGINAL PAPER
Carbon nanoparticles in lateral flow methods to detect genes
encoding virulence factors of Shiga toxin-producing
Escherichia coli
P. Noguera & G. A. Posthuma-Trumpie & M. van Tuil &
F. J. van der Wal & A. de Boer & A. P. H. A. Moers &
A. van Amerongen
Received: 7 July 2010 /Revised: 7 October 2010 /Accepted: 12 October 2010 /Published online: 28 October 2010
# The Author(s) 2010. This article is published with open access at Springerlink.com
Abstract The use of carbon nanoparticles is shown for the
detection and identification of different Shiga toxin-
producing Escherichia coli virulence factors (vt1, vt2, eae
and ehxA) and a 16S control (specific for E. coli) based on
the use of lateral flow strips (nucleic acid lateral flow
immunoassay, NALFIA). Prior to the detection with
NALFIA, a rapid amplification method with tagged primers
was applied. In the evaluation of the optimised NALFIA
strips, no cross-reactivity was found for any of the
antibodies used. The limit of detection was higher than
for quantitative PCR (q-PCR), in most cases between 10
4
and 10
5 colony forming units/mL or 0.1–0.9 ng/μL DNA.
NALFIA strips were applied to 48 isolates from cattle
faeces, and results were compared to those achieved by q-
PCR. E. coli virulence factors identified by NALFIA were
in very good agreement with those observed in q-PCR,
showing in most cases sensitivity and specificity values of
1.0 and an almost perfect agreement between both methods
(kappa coefficient larger than 0.9). The results demonstrate
that the screening method developed is reliable, cost-
effective and user-friendly, and that the procedure is fast
as the total time required is <1 h, which includes
amplification.
Keywords E. coli.Verotoxin.Shiga toxin.Screening
method.Nucleic acid lateral flow immunoassay.Carbon
nanoparticles
Introduction
Detection of pathogenic bacteria is key to the prevention
and identification of problems related to health and safety.
In spite of the real need for obtaining analytical results in
the shortest time possible, traditional and standard bacterial
detection methods, even if of sufficient sensitivity, are often
expensive and too slow to be of any use; some may take up
to 8 days to yield an answer [1, 2]. For this reason, over the
recent years, a lot of effort has gone into the development
of rapid biosensors of diverse nature. However, their
performance is variable and still needs improvement [2].
Most of the reported methods for the detection of
pathogenic bacteria are applied to Escherichia coli [1, 2].
There are many E. coli strains of which quite a number
are part of the normal microbiota in the gut. Although most
of them are harmless, some of them can cause severe
illnesses; one of those is the Shiga toxin-producing E. coli
(STEC, also called verotoxigenic E. coli or enterohemor-
rhagic E. coli)[ 3]. STEC has emerged as a food poisoning
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like diarrhoea, hemorrhagic colitis or haemolytic uraemic
syndrome. The most important reservoirs of STEC, and,
consequently, causes of human infections, are domestic
ruminants, especially cattle and sheep. Since STEC strains
are found as part of the normal intestinal flora of these
animals, transmission occurs through, e.g., consumption of
undercooked meat, unpasteurised dairy products and
vegetables or water contaminated by faeces of carriers
[4, 5]. Even though many STEC serotypes have been
associated with human illness, the vast majority of reported
outbreaks and sporadic cases of STEC infection in humans
have been associated with serotype O157:H7 [5]. Some of
the STEC virulence factors are: cytotoxins (verotoxins)
encoded by the genes vt1 or vt2; the outer membrane
protein intimin encoded by the gene eae and involved in the
attachment to intestine epithelial cells; and the enter-
ohaemolysin encoded by the gene ehxA.
Monitoring and evaluation of E. coli virulence factors
can be done by various methods that include laboratory
culture, typing methods, serological methods, detection of
DNA sequences and immunochemical methods [2, 5, 6].
The need for timely results has increased the interest in
rapid screening methods. This interest is also growing due
to the shift of pathogen testing from laboratories (govern-
mental, reference, etc.) to on-site settings in, e.g. food-
processing plants [1]. Most E. coli-specific methods have a
detection limit between 10
3 and 10
5 cells/mL and some rely
on the amplification of specific genes of the E. coli genome
for specific identification [7, 8]. There are biosensors in the
literature that can detect a lower amount of cells [2, 6], but
in general, these systems have a moderate sensor-to-sensor
reproducibility and poor batch-to-batch reproducibility [9],
whilst others do not comply with the basic requirements for
application in this field, i.e. a low price and ease of use [7].
Moreover, many methods do not distinguish between
E. coli virulence factors/strains.
The use of nucleic acid lateral flow immunoassays
(NALFIA) as biosensors for the detection of specific
amplified nucleic acid genes is not new [10]. In NALFIA,
nucleic acids can be captured on the lateral flow test strips
either in an antibody-independent or antibody-dependent
manner [11, 12]. In the first one, a hybridization step is
required upon running the sample through the membrane
[11–15]. The second and simpler approach uses immobi-
lised antibodies to directly recognise specific tag-labelled
amplicons [11, 12, 16, 17]. Some of the advantages of
using lateral flow strips are: one-step assay, simple, fast,
low cost, versatile and a prolonged shelf life (with no need
for refrigeration) [11, 12, 18–20]. Moreover, compared with
traditional electrophoresis detection, NALFIA has other
advantages like shorter response time and no need for
hazardous reagents [16, 17]. NALFIA strips comply with
most of the requirements for biosensors for bacterial
detection: low detection limit, species selectivity, strain
selectivity, assay time for a single test between 5 and
10 min, no reagent addition needed (except buffer), direct
measurement, highly automated format, no operator skills
needed to carry out the assay, and also compact size,
portable, handheld, and designed for field application [7].
In addition, they comply with two other characteristics: low
price and easy manufacture. Another interesting feature is
that they are disposable; hence, regeneration time is
eliminated. Finally, if NALFIA strips are used with coloured
nanoparticles, a visual detection can be easily performed; in
this sense, this combination overcomes one of the major
shortcomings in the application of immunosensor techni-
ques, which is the cost of the required equipment [8].
The aim of this work was to present the use of carbon
nanoparticles in NALFIAs. Carbon nanoparticles were
chosen for their high signal-to-noise ratio (black to a white
background) [17, 21] and their excellent sensitivity, i.e. low
picomolar by visual inspection [18]. NALFIA was applied
to the rapid detection and identification of genes encoding
various STEC virulence factors (vt1, vt2, eae and ehxA) and
of the gene coding for E. coli 16S rRNA as a control.
Genes were amplified with specific tag-labelled primers,
and amplicons were sandwiched between neutravidin
coated onto carbon nanoparticles and specific anti-tag
antibodies immobilised on the NALFIA nitrocellulose
membrane. The limit of detection of the NALFIA strips
was determined, and the strips were tested with DNA from
48 field strains originating from cattle faeces. Performance
of the NALFIA strips was evaluated by comparing the
results with those achieved by quantitative PCR (q-PCR).
Material and methods
Reagents
Borate buffer (BB) 100 mM, pH 8.8, was prepared by mixing
100 mM solutions of H3BO3 (Merck, Darmstadt, Germany)
and Na2B4O7⋅10 H2O (Sigma-Aldrich Chemie BV,
Zwijndrecht, the Netherlands). BB (5 mM) was obtained
diluting 100 mM BB appropriately. With these two buffers,
bovine serum albumin (BSA, Sigma-Aldrich Chemie BV)
and Tween 20 (Merck, Amsterdam, the Netherlands), several
buffers were prepared: washing buffer (WB, 5 mM BB, 1%
(w/v) BSA), storage buffer (SB, 100 mM BB, 1% (w/v)
BSA) and running buffer (RB, 100 mM BB, 1% (w/v)B S A ,
0.05% (v/v) Tween 20). NaN3 was added to all buffers to a
final concentration of 0.02% (w/v).
Polyclonal antibodies against digoxigenin (DIG, Roche,
Penzberg, Germany), 2,4-dinitrophenol (DNP, Invitrogen
Corporation, Camarillo, CA, USA), fluorescein isothiocya-
832 P. Noguera et al.nate (FITC, AbD-Serotec, Oxford, UK) and Texas Red
(TxR, Invitrogen Corporation) were used. A monoclonal
antibody against Cy5 (Sigma-Aldrich Chemie BV) was
used for the 16S primer anti-tag antibody. As control line,
biotinylated anti-rabbit antibody (Pierce Biotechnology,
Rockford, IL, USA) was used.
E. coli strains and DNA isolation
E. coli strains used as controls are listed in Table 1. These
strains were selected for having different sets of genes
coding for virulence factors. The strains were grown
overnight aerobically at 37 °C on heart infusion agar (Difco
Laboratories, Detroit, MI, USA) supplemented with 5%
sheep blood (HIS plates). DNA was isolated by harvesting
bacteria from a plate with one streak of an inoculation loop
and subsequent resuspension in 300 μL 6% Chelex 100
(Bio-Rad Laboratories, Hercules, CA, USA). The suspen-
sion was heated at 56 °C for 15 min, then at 100 °C for
8 min, and centrifuged at 14,000×g for 5 min. Supernatants
containing genomic DNA were transferred to a new vessel
and stored at −20 °C until use.
To isolate DNA for quantitative purposes, EDL 933 was
grown aerobically at 37 °C in 10 mL Bacto Heart Infusion
Broth (Becton Dickinson, Sparks, MD, USA). A quantity
of 1 mL containing 8.4×10
7 colony forming units (cfu) was
taken from a culture in the exponential growth phase for
DNA isolation using Chelex, resulting in a DNA prepara-
tion with 775 ng/μL.
Polymerase chain reaction
DNA was amplified prior to detection with NALFIA strips.
Primers used in the amplification of the genes coding for
four STEC virulence factors (vt1, vt2, eae and ehxA) and a
16S control specific for E. coli are indicated in Table 2.
Forward primers were labelled with specific tags TxR (vt1),
FITC (vt2), DIG (eae), DNP (ehxA) or Cy5 (16S), whereas
all reverse primers were labelled with biotin (Eurogentec,
Seraing, Belgium). To achieve an amplification reaction in
the shortest time possible with economical equipment, PCR
reactions were carried out with Phire Hot Start DNA
Polymerase (Finnzymes) and a PIKO Thermal cycler
(Finnzymes, Espoo, Finland) using extra thin vessels that
allow an increase in heat transfer speed. Since annealing
temperature may be affected by the use of tags coupled to
primers [22], amplification reactions were optimised with
the final aim of using identical conditions for all genes.
The protocol applied had a total length of 30 min and
consisted of an initial denaturation at 98 °C (30 s),
followed by 30 cycles with a denaturation step at 98 °C
( 5s ) ,a na n n e a l i n gs t e pa t6 1° C( 5s )a n da ne x t e n s i o n
step at 72 °C (5 s), with a final extension step at 72 °C
(1 min) followed by a lowering of temperature to 4 °C.
The reaction tube contained 2 μL template and 0.4 μL
polymerase (as provided in the kit) in a total volume of
20 μL, with final concentrations of 1.5 mM MgCl2,
0.25 μMd N T P sa n d0 . 9μM of each primer (forward and
reverse). Positive and negative controls were included in
all runs. Amplified DNA was directly analysed with a
NALFIA strip or stored at −20 °C until use.
Carbon conjugate
Carbon nanoparticles bind proteins non-covalently and, if
optimal conditions have been applied, without changing
their bioactivity [17, 21, 25, 26]. Therefore, carbon nano-
particles were labelled with neutravidin biotin-binding
protein (Pierce Biotechnology) following O’Keefe et al.
[27]. Briefly, the procedure to obtain the carbon conjugate
was: 10 mg of carbon (Spezial Schwartz 4, Degussa AG,
Frankfurt, Germany) was suspended in 1 mL of MilliQ
water and sonicated for 5 min (Branson model 250 Sonifier,
Danbury, CT, USA). The resulting 1% (w/v) carbon
suspension was fivefold diluted in 5 mM BB and sonicated
for 5 min. Next, 350 μg neutravidin was added to 1 mL of
the diluted carbon suspension and stirred for 3 h at room
temperature. This suspension was first centrifuged at
13,636×g for 15 min; the supernatant was removed and
the pellet washed with WB to remove unbound protein. To
achieve this, 1 mL of WB was added to the pellet and the
mixture centrifuged at 13,636×g for 15 min. Subsequently,
the supernatant was removed and the pellet was resus-
pended in 1 mL WB. This process was repeated twice.
After the final wash, the pellet was resuspended in 1 mL SB
and stored at 4 °C until use. The resulting homogeneous
suspension contained 0.2% (w/v) carbon conjugate.
Nucleic acid lateral flow immunoassay
NALFIA strips were manufactured using nitrocellulose
(NC) membranes cut to a width of 2.5 cm (HiFlow Plus
HFB135, Millipore, Billerica, MA, USA). A Linomat IV
Table 1 Serotypes, sources and virulence factors of selected E. coli
strains
Strain Serotype Source vt1 vt2 eae ehxA
EDL 933 O157:H7 Human + + + +
E32511 O157:H
- Human − +++
DVI 828 O49:Hnd Calf −−++
TB 154A O103:H6 Human + − ++
B2F1 O91:H21 Human − + − +
Rdec-1 O15:NM Rabbit −−+ −
+/−: presence/absence
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dispense the specific antibody (test line) and the biotiny-
lated antibody (control line) on the NC membrane at a dose
of 1 μL/5 mm (diluted in 5 mM BB). Distance between
lines was 5 mm. The NC membranes were dried overnight
at 37 °C. Then, the NC membranes were fixed on a plastic
backing along with a cellulose absorbent pad (Schleicher
and Schuell, ’s-Hertogenbosch, the Netherlands). Finally,
strips were cut at a width of 5 mm using a Bio-Dot Cutter
CM4000 (Irvine, CA, USA), used immediately, or pack-
aged in aluminium pouches (with a silica desiccation pad),
sealed and stored at room temperature until use.
Following PCR, amplicons were detected by means of
NALFIA: The double-tagged amplicons were sandwiched
between neutravidin (bound to carbon nanoparticles) and an
antibody against the discriminating tag (immobilised on the
NC membrane, capture ligand) (see Electronic supplemen-
tary material (ESM) Fig. S1). To achieve this, NALFIA
assays were performed in a low-binding 96-well micro-
plate. Once reagents were introduced in a well and mixed
thoroughly, a strip was dipped vertically and reagents
moved upwards through the strip by capillary force. Strips
used for qualitative results (presence/absence of virulence
factors) were visually examined after 10 min; a positive
result (+) was recorded when a line was distinguishable
from the background, and a negative result (−) when no line
was seen. For quantitative results, strips were dried at
37 °C, and the pixel grey intensity of the test lines was
evaluated following conventional flatbed scanning [28].
Immunoassays need to be optimised for each antibody
with respect to performance and for the set of antibodies
used. To accomplish this, several experiments were per-
formed to find the optimum amount of antibody sprayed on
the NC membranes and the amount of PCR product to be
used. For this, strips were manufactured with serial
dilutions of each of the antibodies and tested with different
amounts of PCR product. For one of the antibodies
(specific to Cy5), the addition of 2% sucrose (Merck,
Darmstadt, Germany) remarkably improved the line quality
[29].
Cross-reactivities were studied by testing all amplified
genes (using EDL 933 diluted 1/100 as template) on each
of the specific NALFIA strips. With the aim of identifying
several STEC genes simultaneously, a series of strips was
prepared onto which all antibodies were printed. In this
case, the width of the NC membrane used was 5 cm and the
distance between lines 3 mm.
To evaluate the analytical performance of the NALFIA
stripsdeveloped,DNAofE. coli strain EDL 933 (775 ng/μL,
corresponding with 8.4 × 10
7 cfu/mL) was subjected to
tenfold serial dilutions and divided into six aliquots. Three
aliquots were used in the optimised PCR amplification
procedure, and for each aliquot, two NALFIA strips were
used. For comparison, the remaining three aliquots were
analysed using the reference method, q-PCR. For each
factor, dried strips were scanned, data (in pixel grey
volumes) were transformed to percentage of the maximum,
and the resulting percentages were adjusted to a four-
parameter logistic curve (Sigmaplot 11, Systat Software,
Inc., San Jose, CA, USA). The limit of detection (LOD) was
calculated as the signal of the blank plus three times the
standard deviation of the blank (SD). For simplicity of
interpretation, all quantitative results will be given in colony
forming units per millilitre.
Table 2 Primer and probe sequences used for the amplification of different E. coli virulence factors
Primer or probe Sequence Amplicon size (bp) Reference
vt1-F 5′-GGATAATTTGTTTGCAGTTGATGTC-3′ 107 [23]
vt1-R 5′-CAAATCCTGTCACATATAAATTATTTCGT-3′
vt1-P 5′-CCGTAGATTATTAAACCGCCCTTCCTCTGGA-3′
vt2-F 5′-GGGCAGTTATTTTGCTGTGGA-3′ 130 [23]
vt2-R 5′-GAAAGTATTTGTTGCCGTATTAACGA-3′
vt2-P 5′-ATGTCTATCAGGCGCGTTTTGACCATCTT-3′
eae-F 5′-CATTGATCAGGATTTTTCTGGTGATA-3′ 102 [23]
eae-R 5′-CTCATGCGGAAATAGCCGTTA-3′
eae-P 5′-ATAGTCTCGCCAGTATTCGCCACCAATACC-3′
ehxA-F 5′-CGTTAAGGAACAGGAGGTGTCAGTA-3′ 142 [23]
ehxA-R 5′-ATCATGTTTTCCGCCAATGAG-3′
ehxA-P 5′-TCATAAGGAATTCCACCGGTTCTGAATTCA-3′
16S-F 5′-CATGCCGCGTGTATGAAGAA-3′ 96 [24]
16S-R 5′-CGGGTAACGTCAATGAGCAAA-3′
16S-P 5′-TATTAACTTTACTCCCTTCCTCCCCGCTGAA-3′
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To identify whether an isolate isan STEC, q-PCR can be used
to detect the various virulence factors and was used as the
reference method in this work. Reaction mixtures for q-PCR
were assembled in 20-μL quantities using the TaqMan Fast
Universal PCR Master mix according to the manufacturer’s
instructions (Applied Biosystems, Nieuwerkerk a⁄d IJssel, the
Netherlands)with2-μLtemplateDNA.PCRswereperformed
using the same primers as used for PCR preceding NALFIA
(see above; Table 2) and TaqMan probes labelled with the
fluorescent dyes 6-FAM or VIC at the 5′ end and a quencher
at the 3′ end, i.e. TAMRA for the vt1, vt2, eae and ehxA
probes (Applied Biosystems) and BHQ for the 16S probe
(Eurogentec, Table 2). The PCRs were performed on an
Applied Biosystems 7500 Fast Real-Time PCR System in
Fast 7500 run mode using the standard thermal cycler
protocol. Positive and negative controls were included in all
runs; the cutoff was set at a Ct of 32 based on results with
negative controls. All PCRs were performed in duplex
reactions (vt1/vt2, eae/ehxA) or in a single reaction (16S).
Field samples
To test field samples, DNA was obtained from 48 E. coli
isolates originating from cattle faeces [30]. The isolated
DNA was subjected (in duplicate) to the 30-min PCR
amplification and subsequently to a NALFIA test strip. The
result achieved for each single sample (i.e. the presence or
absence of a virulence factor) was compared with the result
achieved by q-PCR. When results were identical, it was
considered as a true positive (or negative), and when they
differed it was considered a false positive (or negative).
With these values, several reliability parameters were
calculated to evaluate the performance of the NALFIA
strips [31–33]: sensitivity, specificity, positive (and nega-
tive) predictive values, and efficiency. At present, there is
no agreement which of these previous parameters is the
most useful one, and there are no guidelines to evaluate
results achieved. For this reason, the kappa coefficient (k)
was also calculated. This statistic coefficient takes into
account the possibility of chance agreement, and Landis
and Koch [34] provided a starting point to evaluate the
strength of the agreement. The use of k does not exclude the
use of other parameters since predictive values are
interpretable as indices of test performance (how well a
sample is classified), whereas k is interpretable as an index
of test quality (how well a test makes use of evidence in
classifying samples) [33].
The mathematical equations to calculate all these
reliability parameters are given in ESM Table S1, and an
Excel spreadsheet specifically developed for evaluating
diagnostic tests was used [35].
Results and discussion
Nucleic acid lateral flow immunoassay
NALFIA strips were manufactured with serial dilutions of
eachoftheantibodiesandwereusedwithdifferentamountsof
PCR product. Line intensity increased with increasing
amounts of antibody and PCR product (until a maximum
plateau value was reached). The selected final assay con-
ditions were those that achieved good line intensity using the
lowestamountofantibody(tomakethestripsascost-effective
as possible) and the lowest volume of PCR product. For
convenience, the final PCR volume used was the same for all
factors tested. Examples regarding the selection of optimal
conditions are given in the ESM attached.
The selected optimal amount of antibody sprayed on the
NC membrane was: 100 μg/mL for TxR (vt1), DIG (eae)
and biotinylated IgG (control); 125 μg/mL for DNP (ehxA);
250 μg/mL for FITC (vt2); and 300 μg/mL (in 2% (w/v)
sucrose) for Cy5 (16S). Strips were finally used in micro-
plate wells that contained a mixture of 1 μL of PCR
product (sample), 1 μL carbon–neutravidin conjugate and
98 μL RB.
To verify that there was no cross-reactivity, optimised
strips for the identification of each of the genes were used
with all other amplicons, and no cross-reactivity was found.
NALFIA strips were also tested with different E. coli
strains (Table 1) and a blank (water). Once samples had
been randomly identified by a number, they were submitted
to PCR and their products applied to the optimised
NALFIA strips. All genes coding for the virulence factors
were correctly identified, allowing the identification of the
six E. coli strains used (see ESM Table S2). These results
were very promising with respect to testing real field
samples.
When NALFIA strips were used with different E. coli
dilutions (submitted to PCR amplification), maximum
intensity values was around 10
5 pixel grey volumes. When
data were transformed to percentage of the maximum
signal, differences in the performance of NALFIA strips
having different antibodies were noticeable (Fig. 1). For all
systems, the regression values for the adjustment of these
data to a four-parameter logistic curve were larger than
0.97, and the LOD increased in the following order:
vt2<ehxA<16S<eae<vt1 (Table 3), being around 10
5
cfu/mL (0.9 ng/μL), which would correspond to 200 cfu
in the PCR tube. The lowest LOD was achieved for vt2
with a value of 6.7 10
4 cfu/mL (0.6 ng/μL). LODs of the
NALFIA strips developed are similar to those achieved by
other systems for the detection of E. coli [8], but in our
study, virulence factors were specifically identified.
When comparing the LODs of NALFIA strips with those
of q-PCR, the LOD achieved by q-PCR in most cases was
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(Table 3). The sole exception is vt2; the LOD achieved in q-
PCR (5.9 10
5 cfu/mL or 5.4 ng/μL) was higher than the one
for NALFIA (6.7 10
4 cfu/mL or 0.6 ng/μL). As can be
noted, the order of sensitivity achieved by q-PCR is almost
contrary to the one achieved by NALFIA strips. These
differences in LOD will explain the performance of the
NALFIA strips with real samples (presence of false results;
see “Field samples”).
Field samples
DNA of each of the 48 cattle faeces isolates was amplified
by PCR (30 min) and the resulting amplicons applied to
NALFIA tests. The qualitative result achieved for each
sample (presence/absence) was compared to the result
achieved by q-PCR (considered in this work as the
reference method). The results achieved for each virulence
factor tested are summarised in Table 4 (see ESM Table S1
for clarification). The presence of FP and FN results is
justified by the different performance (LOD) of NALFIA
and q-PCR for each of the amplified virulence factors. The
three FN found for vt1 and the one found for ehxA are due
to the higher LOD of the NALFIA strips (compared to q-
PCR); E. coli was present, but in a concentration that was
not detected [36, 37]. On the other hand, the two FP
achieved for vt2 can be explained if the lower LOD for
NALFIA is taken into account (one order of magnitude
lower than for q-PCR); that is, in this particular sample, this
factor was not detected by q-PCR.
Reliability parameters of the NALFIA strips developed
are indicated in Table 5 (standard error values are given in
ESM Table S3). For all factors tested, sensitivity and
specificity values were very high (larger than 0.85, and in
most cases equal to 1.00). In all cases, positive and negative
predictive values (i.e. how well a sample is classified) were
larger than 0.90. Moreover, efficiency values (i.e. correct
answers) were 0.92 or greater, meaning that more than 90%
of the answers were the same as the reference procedure.
The kappa coefficient was also calculated, giving values
larger than 0.80 and in some cases equal to 1.00. According
to Landis and Koch [34], this indicates that there is an
almost perfect agreement between NALFIA and the
standard used (q-PCR) for vt1, vt2 and ehxA, and a perfect
agreement for eae and 16S. This excellent agreement
between the NALFIA strips developed and the reference
system used demonstrates that the proposed analytical
procedure has been proven to be fit for purpose, i.e. it is
valuable for fast screening of E. coli virulence factors.
A preliminary multi-analyte NALFIA was prepared with
five test lines (one for each of the specific antibodies: TxR,
FITC, DIG, DNP and Cy5) and one control line (biotiny-
lated anti-rabbit IgG) with the conditions indicated
previously. These NALFIA strips were tested for cross-
reactivities (Fig. 2) by running a blank sample (first strip),
each of the STEC factors (second to sixth strip), and a
sample with all factors (seventh strip). As previously noted,
no cross-reactivity was found and all specific amplicons
were correctly identified, showing the potential of NALFIA
strips for the simultaneous detection of multiple virulence
factors.
Conclusions
The performance of the NALFIA strips developed in this
work (with a preceding 30-min PCR reaction step) has
shown that this system is feasible and reliable and that it
allows the specific identification of the four E. coli
virulence genes (vt1, vt2, eae and ehxA) and a marker
specific for E. coli in approximately 40 min (once DNA is
isolated). Results achieved for the detection of E. coli
virulence factors in real samples by NALFIA (following
DNA isolation and PCR amplification) were in very good
agreement with those achieved by q-PCR. Most discrep-
ancies can be explained by the different LODs for the
various genes in both methods. Nevertheless, NALFIA
strips developed have very good sensitivity and specificity,
cfu/mL
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Fig. 1 Sensitivity of the various NALFIAs for each of the E. coli
virulence factors tested. Average ± SD (n=6)
Table 3 Detection limit achieved by NALFIA and q-PCR for
different E. coli virulence factors
Detection limit (cfu/mL)
vt1 vt2 eae ehxA 16S
NALFIA 4.1×10
5 6.7×10
4 3.7×10
5 1.4×10
5 1.8×10
5
q-PCR 8.4×10
2 5.9×10
5 8.4×10
3 8.4×10
3 8.4×10
1
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agreement with the reference method used (q-PCR). When
comparing both systems, q-PCR could have the advantage
that (in most cases) the LOD is lower than NALFIA and
that the identification is done in one step. However, it has
several drawbacks: The first one is the price of the
equipment, the second one is that specific knowledge is
needed to understand and interpret the results, and the third
one is the need of a laboratory setting. When comparing the
number of factors that can be analysed, for q-PCR, only a
limited number of fluorescent dyes are available, and
multiplexing is complicated by the spectral overlap of the
various dyes, allowing only a limited combination of dyes
in one run (generally up to six). However, as verified in this
work, NALFIA strips can also be manufactured with six
lines (five test lines and one control line), having several
advantages over more sophisticated instrumentation as
listed above. Moreover, the same carbon–neutravidin nano-
particle conjugate is presently used to sandwich tag-labelled
amplicons in antibody microarrays (results from Wagenin-
gen UR Food & Biobased Research, manuscript in
preparation). In this format, the number of discrete targets
can be easily increased by introducing other tag–antibody
combinations. The results of this approach, a 30-min
amplification followed by a one-step incubation for 1 h
on the microarray, can be obtained by automated data
processing following the digitisation of the spots by flatbed
scanning or digital photography (10-min total processing
time). Finally, if the price per test would be compared,
NALFIA is less costly than q-PCR. The price for a duplex
q-PCR test (e.g. virulence gene and 16S control) was
calculated to be €1.16 (provided multiple samples are tested
in the 96-well microtiter plate format). On the other hand,
cost calculation for a two-line NALFIA (duplex PCR)
resulted in €0.41. In conclusion, the NALFIA technology
enables a larger multiplexing than q-PCR, is substantially
less demanding with respect to laboratory facilities and has
a lower price per test.
In this work, it has been demonstrated that the use of
NALFIA strips in combination with a quick PCR amplifi-
cation step comprises most of the requirements for
alternative rapid methods [6]: accurate, with very good
sensitivity and specificity, reliable, and with a detection
limit that enables the correct discrimination of the different
E. coli virulence factors. The test has also been validated
against a standard test (q-PCR), its speed is high (<40 min,
once the enrichment step is performed), and the cost of the
whole system (strips, reagents) is low, requiring only one
instrument (the thermocycler). Other characteristics that this
system meets are that NALFIA strips are easily manufac-
tured, have a long shelf life, can be stored under ambient
conditions, and are very easy to use. In addition, whilst for
q-PCR often small fragments are chosen (100–150 bp), the
size of amplicon targets is not critical in NALFIA. This
would allow using larger fragments if the variation in a
particular region would require so.
Potentially, the developed NALFIA system can be used
in the field, near the animal that has to be tested on
(zoonotic) pathogens. In that case, transportation of infected
samples to testing laboratories would not be necessary,
Control 
-TxR (vt1) 
-FITC (vt2) 
-DNP (ehxA) 
-DIG (eae) 
-Cy5 (16S) 
B vt1 vt2 ehxA eae 16S    all
Control 
α-TxR (vt1) 
α vt2) 
α-DNP (ehxA) 
α-DIG (eae) 
α-Cy5 (16S) 
B vt1 vt2 ehxA eae 16S    all
Fig. 2 Results achieved with multi-analyte NALFIA for E. coli
virulence factors. Samples: blank (first strip), each of the STEC factors
(second to sixth strip), and all factors (seventh strip)
Methods Reference method (q-PCR)
vt1 vt2 eae ehxA 16S
pos. neg. pos. neg. pos. neg. pos. neg. pos. neg.
NALFIA pos. 17 1 30 2 23 0 31 0 47 0
neg. 3 27 0 16 0 25 1 16 0 1
Table 4 Comparison of qualita-
tive results achieved in isolates
from cattle faeces for different
E. coli virulence factors
pos. number of positive sam-
ples, neg. number of negative
samples
Table 5 Reliability parameters for different E. coli virulence factors
vt1 vt2 eae ehxA 16S
Sensitivity 0.85 1.00 1.00 0.97 1.00
Specificity 0.96 0.89 1.00 1.00 1.00
Positive predictive value 0.94 0.94 1.00 1.00 1.00
Negative predictive value 0.90 1.00 1.00 0.94 1.00
Efficiency 0.92 0.96 1.00 0.98 1.00
Kappa coefficient (k) 0.83 0.91 1.00 0.95 1.00
Carbon nanoparticles in lateral flow methods to detect genes 837therebyreducingtheriskofcontaminationoutsidetheplaceof
identification. The user friendliness of the procedure can be
further improved by applying ready-to-use amplification
reagents combined with isothermal amplification protocols
and on-tissue amplification protocols that would make DNA
isolation superfluous. No expensive apparatus is needed to
perform the test procedure, and the number of specific
amplicons thatcan betestedsimultaneouslyisonlydependent
on the availability of tag–antibody combinations and on the
possibility to develop a multiplex PCR protocol. Moreover,
thedetectionsystemisbroadlyapplicablesinceanymolecular
biological diagnostic question can be translated in primer sets
having biotin on one of the primers and a discriminating tag
on the other primer. A carbon conjugate with neutravidin (or
streptavidin) will always recognise double-labelled amplicons
having a biotin on one end of the double-strand chain, and
specific anti-tag antibodies on the membrane willbind to their
respective tags, thereby revealing the identity of the specific
amplicons. Integration of the NALFIA technology in a field-
applicable device with which amplification can be done,
would further decreasehands-ontime and simplifythe overall
detection procedure.
Inconclusion, wehavedemonstratedthatthe use ofcarbon
nanoparticles to detect amplified double-strand genetic
material by NALFIA results in a screening method that is
reliable, simple to use, cost-effective and fast; once DNA is
isolated, results are achieved within 40 min, including the
amplification step.
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